Free Guide: The evolving landscape of EGFR in NSCLC

EGFR exon 20 insertions represent a subset of EGFR-mutant lung cancer and are a heterogeneous group of mutations. Conventional PCR methods can miss EGFR exon 20 insertions, thus molecular profiling with next-generation sequencing (NGS) technology enables precise identification and characterization of exon 20 insertions in clinical research. Download this guide to learn more about the evolving landscape of EGFR in NSCLC.

First Name

Last Name

Name of Institution

Telephone

City

Are you interested in receiving a demo about the Oncomine NGS Assays and Genexus NGS System for EGFR exon 20 insertion biomarker testing in clinical research?

Yes

본 개인정보를 Thermo Fisher Scientific 그룹에 제공하는 것에 대해 동의하십니까?*

Thermo Fisher Scientific 그룹에서 발송하는 이메일 수신에 동의 하십니까?

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.